Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1469 Articles

Chris Lange | Mar 6, 2017 at 9:50 AM EST

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type…

Chris Lange | Feb 28, 2017 at 8:55 AM EST

Why Short Sellers Are Making a Massive Bet in Major Pharma

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.

Trey Thoelcke | Feb 28, 2017 at 6:15 AM EST

The 6 Most Shorted NYSE Stocks

The nearly eight-year old bull market endures, with markets recently hitting all-time highs. And how are short sellers reacting?

Paul Ausick | Feb 23, 2017 at 4:01 PM EST

Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday

Johnson & Johnson, Pfizer, UnitedHealth, and Verizon lifted the DJIA on Thursday.

Paul Ausick | Feb 16, 2017 at 12:45 PM EST

Apple Named World’s Most Innovative Company

2016's 50 most innovative companies are topped by Apple, Google and Tesla. Among the companies making the biggest moves were…

Paul Ausick | Feb 15, 2017 at 4:01 PM EST

Pfizer, Cisco Push DJIA Higher Wednesday

Pfizer, Cisco, JPMorgan, and Procter & Gamble lead the DJIA to another record high on Wednesday.

Chris Lange | Feb 10, 2017 at 8:35 AM EST

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far…

Chris Lange | Jan 31, 2017 at 8:55 AM EST

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

When Pfizer reported its fourth-quarter financial results before the markets opened on Tuesday, earnings fell short of consensus estimates.

Chris Lange | Jan 30, 2017 at 11:45 AM EST

Top 7 Earnings Reports to Look For Tuesday

24/7 Wall St. has put together a preview of some of the major companies reporting on Tuesday, including Apple and…

Chris Lange | Jan 29, 2017 at 10:25 AM EST

What to Expect From Dow Stocks Reporting This Week

Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the…

Chris Lange | Jan 26, 2017 at 9:50 AM EST

Short Sellers Run for Cover From Major Pharma

The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | Jan 20, 2017 at 11:25 AM EST

5 Worst Performing Dow Stocks of 2017

Even though the new year is barely three weeks old, it's not too soon to take a look at how…

Paul Ausick | Jan 19, 2017 at 4:01 PM EST

Exxon Mobil, Merck Weigh on DJIA Thursday

Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.

Paul Ausick | Jan 17, 2017 at 4:01 PM EST

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

JPMorgan, Goldman Sachs, Pfizer, and UnitedHealth sink DJIA on Tuesday.

Paul Ausick | Jan 12, 2017 at 4:01 PM EST

Disney, Microsoft Lead DJIA Drop Thursday

Disney, Microsoft, Pfizer, and Intel lead DJIA to lower close on Thursday.

1 … 41 42 43 44 45 … 98

Pfizer : PFE

All Pfizer Articles

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Short Sellers Are Making a Massive Bet in Major Pharma

The 6 Most Shorted NYSE Stocks

Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday

Apple Named World’s Most Innovative Company

Pfizer, Cisco Push DJIA Higher Wednesday

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

Top 7 Earnings Reports to Look For Tuesday

What to Expect From Dow Stocks Reporting This Week

Short Sellers Run for Cover From Major Pharma

5 Worst Performing Dow Stocks of 2017

Exxon Mobil, Merck Weigh on DJIA Thursday

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

Disney, Microsoft Lead DJIA Drop Thursday

Tesla Just Ripped 19% in a Month. Is It Time to Sell in May and Go Away?

XRP Price: Why $35 Million in Binance Selling Couldn’t Crack XRP’s $1.40 Support

Here Are Friday’s Top Wall Street Analyst Research Calls: Applied Materials, Devon Energy, Epam Systems, HubSpot, Nike, Shake Shack, Tapestry, Qualcomm, and More

Apple's $100 Billion Bet: Could Buying Back Stock Beat Building AI Data Centers

3 Higher-Yield Alternatives to a Traditional Savings Account

Tesla Just Ripped 19% in a Month. Is It Time to Sell in May and Go Away?

XRP Price: Why $35 Million in Binance Selling Couldn’t Crack XRP’s $1.40 Support

Pfizer : PFE

All Pfizer Articles

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Short Sellers Are Making a Massive Bet in Major Pharma

The 6 Most Shorted NYSE Stocks

Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday

Apple Named World’s Most Innovative Company

Pfizer, Cisco Push DJIA Higher Wednesday

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

Top 7 Earnings Reports to Look For Tuesday

What to Expect From Dow Stocks Reporting This Week

Short Sellers Run for Cover From Major Pharma

5 Worst Performing Dow Stocks of 2017

Exxon Mobil, Merck Weigh on DJIA Thursday

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

Disney, Microsoft Lead DJIA Drop Thursday

Tesla Just Ripped 19% in a Month. Is It Time to Sell in May and Go Away?

XRP Price: Why $35 Million in Binance Selling Couldn’t Crack XRP’s $1.40 Support

Here Are Friday’s Top Wall Street Analyst Research Calls: Applied Materials, Devon Energy, Epam Systems, HubSpot, Nike, Shake Shack, Tapestry, Qualcomm, and More

Featured Reads

Apple's $100 Billion Bet: Could Buying Back Stock Beat Building AI Data Centers

3 Higher-Yield Alternatives to a Traditional Savings Account